PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study challenges long-held assumption of gene expression in embryonic stem cells

2013-07-03
(Press-News.org) CAMBRIDGE, Mass. (July 3, 2013) – Whitehead Institute researchers have determined that the transcription factor Nanog, which plays a critical role in the self-renewal of embryonic stem cells, is expressed in a manner similar to other pluripotency markers. This finding contradicts the field's presumptions about this important gene and its role in the differentiation of embryonic stem cells.

A large body of research has reported that Nanog is allelically regulated—that is, only one copy of the gene is expressed at any given time—and fluctuations in its expression are responsible for the differences seen in individual embryonic stem (ES) cells' predilection to differentiate into more specialized cells. These studies relied on cells that had a genetic marker or reporter inserted in the DNA upstream of the Nanog gene. This latest research, published in this week's edition of the journal Cell Stem Cell, suggests that results from studies based on this approach could be called into question.

To quantify the variations in Nanog expression, Dina Faddah, a graduate student in the lab of Whitehead Institute Founding Member Rudolf Jaenisch, looked at hundreds of individual mouse ES cells with reporters inserted immediately downstream of the Nanog gene. One Nanog allele had a green reporter, while the other had a red reporter, allowing Faddah to determine which of the two alleles was being expressed.

After analyzing the results and comparing them to the expression of a "housekeeping" gene and other pluripotency factors, Faddah concluded that, regardless of the cells' growing environment, most ES cells express both Nanog alleles and the variability of this expression corresponds to that of the other genes.

When Faddah tested the established method of inserting a reporter upstream of Nanog, her results reflected the earlier studies' conclusions. However, when she checked the results with other forms of gene expression analysis, she found that the method was not a faithful indicator of Nanog's expression.

"The way the reporter was inserted into the DNA seems to disrupt the regulation of the alleles, so that when the reporter says Nanog isn't being expressed, it actually is," says Faddah.

For Jaenisch, this is an instructional tale that should be heeded by all geneticists.

"Clearly, the conclusions for this particular gene need to be reconsidered," says Jaenisch, who is also a professor of biology at MIT. "And it raises the question for other genes. For some genes, there might be similar issues. For other genes, they might be more resistant to this type of disturbances caused by a reporter."

### This work is supported Vertex Scholars Program, the National Science Foundation (NSF), Jerome and Florence Brill Fellowship, Croucher and Ludwig Research Fellowship, the National Institutes of Health (NIH) (1 F32 GM099153-01A1, HD 045022 and R37CA084198).

Written by Nicole Giese Rura

Rudolf Jaenisch's primary affiliation is with Whitehead Institute for Biomedical Research, where his laboratory is located and all his research is conducted. He is also a professor of biology at Massachusetts Institute of Technology. Full Citation:

"Single-cell analysis reveals that expression of Nanog is biallelic and equally variable as that of other pluripotency factors in mouse embryonic stem cells"

Cell Stem Cell, July 3, 2013.

Dina A. Faddah (1,2), Haoyi Wang (1), Albert Wu Cheng (1,3), Yarden Katz (1,4), Yosef Buganim (1), Rudolf Jaenisch (1,2).

1. Whitehead Institute for Biomedical Research, Cambridge, MA 02142 2. Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139 3. Department of Computation and Systems Biology, Massachusetts Institute of Technology, Cambridge, MA 02139 4. Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139


ELSE PRESS RELEASES FROM THIS DATE:

New papers identify a microRNA that drives both cancer onset and metastasis

2013-07-03
BOSTON -- A mere 25 years ago, noncoding RNAs were considered nothing more than "background noise" in the overall genomic landscape. Now, two new studies reveal that one of these tiny noncoding molecules – microRNA-22 – plays an outsized role in two types of cancer. Reported on-line today in the journals Cell and Cell Stem Cell, the two papers demonstrate in mouse models that miR-22 drives both the onset and spread of breast cancer, as well as the onset of blood cancer. The findings, led by investigators at Beth Israel Deaconess Medical Center (BIDMC), further suggest ...

Hot flashes take heavier toll on women with HIV

2013-07-03
CLEVELAND, Ohio (July 3, 2013)—Women with HIV are living longer, so more are entering menopause. As they do, they suffer more severe hot flashes than women without HIV, and their hot flashes take a heavier toll on their quality of life and daily functioning, found researchers at Massachusetts General Hospital. Their study was published online today in Menopause, the journal of The North American Menopause Society. That toll has the potential to undermine an already shaky foundation for their lives, compromising their health, HIV treatment, and ability to abstain from ...

Immune-boosting colorectal cancer drug shows promise

2013-07-03
Lugano-Barcelona-- New data on an emerging treatment that aims to fight colorectal cancer by stimulating the immune system have been presented at the ESMO 15th World Congress on Gastrointestinal Cancer. The findings confirm the biological action of the drug called MGN1703 and suggest it may be possible to identify which gastrointestinal cancer patients will benefit most from the treatment, reported Prof Hans-Joachim Schmoll from Martin Luther University, Halle, Germany. MGN1703 is a small DNA molecule recognised by a receptor --called toll-like receptor 9-- that is ...

Lifesaving HIV treatment could reach millions more people following landmark study

2013-07-03
Millions more people could get access to life-saving HIV drug therapy, following a landmark study led by Australian researchers based at the Kirby Institute at the University of New South Wales (UNSW). The researchers have found a lower daily dose of an important HIV drug therapy is safe and as effective in suppressing the virus as the standard recommended dose. The findings have been presented at the International AIDS Society Conference in Kuala Lumpur, Malaysia. "This has the potential to affect the treatment of millions of HIV positive people," says UNSW Professor ...

After millennia of mining, copper nowhere near 'peak'

2013-07-03
New research shows that existing copper resources can sustain increasing world-wide demand for at least a century, meaning social and environmental concerns could be the most important restrictions on future copper production. Researchers from Monash University have conducted the most systematic and robust compilation and analysis of worldwide copper resources to date. Contrary to predictions estimating that supplies of this important metal would run out in around 30 years, the research has found there are plenty of resources within the reach of current technologies. ...

Mobile at university -- Fit for life

2013-07-03
Jena (Germany) Spain, France and Great Britain – these are the favourite countries of young Germans who study abroad under the ERASMUS programme. More and more German students consider one or two terms at a university abroad an essential part of their CVs. As a consequence, the number of students who spent some time at a foreign university has more than doubled over the last few years and it is estimated that about a quarter of all German students have gained some form of international experiences. And that is worth it – not only in terms of university and career success. ...

Gasification method turns forest residues to biofuel with less than a euro per liter

2013-07-03
According to the new research results of the VTT Technical Research Centre of Finland, lignocellulosic biomass can be used in the production of high-quality biofuels for the price of less than one euro per litre. A new technology developed in Finland allows the transfer of more than half the energy of wood raw materials to the end-product. The technology is considered ready for the construction of a commercial-scale production plant in Europe. VTT has assessed the techno-economics of the production of renewable liquid transportation fuels from forest residues. The case ...

EULAR issues updated rheumatoid arthritis management recommendations

2013-07-03
The European League Against Rheumatism (EULAR) has released updated recommendations for the management of RA. According to this latest guidance, treatment with disease-modifying anti-rheumatic drugs (DMARDs) should be initiated as soon as a diagnosis of RA is made, with the aim of reaching a target of remission or low disease activity in every patient. As first-line treatment, EULAR recommends rheumatologists administer methotrexate (MTX) or combination therapy of MTX with other conventional synthetic DMARDs. Low-dose glucocorticoids should also be considered in combination ...

New evidence suggests impulsive adolescents more likely to drink heavily

2013-07-03
Scientists at the University of Liverpool have shown that young people who show impulsive tendencies are more prone to drinking heavily at an early age. The research suggests that targeting personality traits, such as impulsivity, could potentially be a successful intervention in preventing adolescent drinking from developing into problems with alcohol in later life. Studies in the UK show that approximately 24% of 12 year olds have reported at least one episode of alcohol consumption, rising to 77% of 15 year olds. Previous research has suggested that impulsive ...

Reproductive BioMedicine Online publishes study on assisted reproduction

2013-07-03
Amsterdam, July 3, 2013 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of a recent retrospective study in Reproductive BioMedicine Online to better understand treatment considerations and outcomes for same-sex male couples and single men when using assisted reproduction treatment. The number of same-sex male couples and single men using assisted reproduction assistance to have a family has been increasing over time (since 2003 a 21-fold increase has been reported). However, there ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] Study challenges long-held assumption of gene expression in embryonic stem cells